Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombophilic risk factors and peripheral arterial disease severity.

Thrombosis and haemostasis - 1 Jul 2010

Sartori Michelangelo, Favaretto Elisabetta, Legnani Cristina, Cini Michela, Conti Eleonora, Amato Alfio, Palareti Gualtiero

Abstract excerpt

Few data are available on thrombophilic risk factors and progression of atherosclerotic peripheral arterial disease (PAD). Thrombophilic alterations can be an aggravating factor when arterial stenoses are present. In a cross-sectional study, we evaluated the presence of the thrombophilic factors fibrinogen, homocysteine, factor (F)VIII, lupus anticoagulant (LAC), FII G20210A, and FV R506Q mutations in 181...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Constriction, Pathologic
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinogen

Share to Ischemia

Share to Lupus Coagulation Inhibitor

Share to Peripheral Arterial Disease

Share to Prothrombin

Share to Thrombophilia

Source

Identifiers

PMID: 20390230
DOI: 10.1160/TH09-11-0772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombophilic risk factors and peripheral arterial disease severity.PMID 20390230Read ↗

G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.Semantic proximity Read ↗

Thrombophilic risk factors for symptomatic peripheral arterial disease.Semantic proximity Read ↗

[Thrombophilias and peripheral arterial occlusive disease].Semantic proximity Read ↗

Vascular ageing: Underlying mechanisms and clinical implicationsSemantic proximity Read ↗

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study.Semantic proximity Read ↗

Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.Semantic proximity Read ↗

Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial DiseaseSemantic proximity Read ↗

Functional, genetic and biochemical biomarkers of peripheral arterial disease.Semantic proximity Read ↗

[Epidemiology of lower extremity artery disease].Semantic proximity Read ↗

MTHFR 677C>T (rs1801133) variant is associated with homocysteinemia but not with clinical severity in patients with peripheral arterial occlusive diseaseSemantic proximity Read ↗

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.Semantic proximity Read ↗

Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.